These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9668360)

  • 41. Depolarization and neurotrophins converge on the phosphatidylinositol 3-kinase-Akt pathway to synergistically regulate neuronal survival.
    Vaillant AR; Mazzoni I; Tudan C; Boudreau M; Kaplan DR; Miller FD
    J Cell Biol; 1999 Sep; 146(5):955-66. PubMed ID: 10477751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural determinants of Trk receptor specificities using BDNF-based neurotrophin chimeras.
    Lai KO; Glass DJ; Geis D; Yancopoulos GD; Ip NY
    J Neurosci Res; 1996 Dec; 46(5):618-29. PubMed ID: 8951673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo.
    Kumar S; Kahn MA; Dinh L; de Vellis J
    J Neurosci Res; 1998 Dec; 54(6):754-65. PubMed ID: 9856859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A signaling organelle containing the nerve growth factor-activated receptor tyrosine kinase, TrkA.
    Grimes ML; Beattie E; Mobley WC
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9909-14. PubMed ID: 9275225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 4-Methylcatechol stimulates phosphorylation of Trk family neurotrophin receptors and MAP kinases in cultured rat cortical neurons.
    Sometani A; Nomoto H; Nitta A; Furukawa Y; Furukawa S
    J Neurosci Res; 2002 Nov; 70(3):335-9. PubMed ID: 12391593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GM1 Ganglioside: Past Studies and Future Potential.
    Aureli M; Mauri L; Ciampa MG; Prinetti A; Toffano G; Secchieri C; Sonnino S
    Mol Neurobiol; 2016 Apr; 53(3):1824-1842. PubMed ID: 25762012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p75 and Trk: a two-receptor system.
    Chao MV; Hempstead BL
    Trends Neurosci; 1995 Jul; 18(7):321-6. PubMed ID: 7571013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase.
    Buj-Bello A; Adu J; Piñón LG; Horton A; Thompson J; Rosenthal A; Chinchetru M; Buchman VL; Davies AM
    Nature; 1997 Jun; 387(6634):721-4. PubMed ID: 9192899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nerve growth factor derived from terminals selectively increases the ratio of p75 to trkA NGF receptors on mature sympathetic neurons.
    Miller FD; Speelman A; Mathew TC; Fabian J; Chang E; Pozniak C; Toma JG
    Dev Biol; 1994 Jan; 161(1):206-17. PubMed ID: 8293873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GM1 and nerve growth factor modulate mitochondrial membrane potential and neurofilament light mRNA expression in cultured dorsal root ganglion and spinal cord neurons during excitotoxic glutamate exposure.
    Huang F; Dong X; Zhang L; Zhang X; Zhao D; Bai X; Li Z
    J Clin Neurosci; 2010 Apr; 17(4):495-500. PubMed ID: 20171893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retinoic acid induced differentiation is mediated by trkB receptors.
    Lucarelli E; Kaplan D; Matsumoto K; Sickafuse S; Thiele CJ
    Prog Clin Biol Res; 1994; 385():185-98. PubMed ID: 7972211
    [No Abstract]   [Full Text] [Related]  

  • 52. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
    Delsite R; Djakiew D
    J Androl; 1996; 17(5):481-90. PubMed ID: 8957691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The semisynthetic glycosphingolipid LIGA20 potently protects neurons against apoptosis.
    Saito M; Guidotti A; Berg MJ; Marks N
    Ann N Y Acad Sci; 1998 Jun; 845():253-62. PubMed ID: 9668359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strategies for modulating Trk receptor activity.
    Hempstead BL
    Exp Neurol; 1993 Nov; 124(1):31-5. PubMed ID: 8282076
    [No Abstract]   [Full Text] [Related]  

  • 55. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E; Peterson S; Maekawa K; Matsushima H
    Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GM1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter systems.
    Hadjiconstantinou M; Neff NH
    J Neurochem; 1998 Apr; 70(4):1335-45. PubMed ID: 9523549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Turning the spotlight on the oligosaccharide chain of GM1 ganglioside.
    Chiricozzi E; Di Biase E; Lunghi G; Fazzari M; Loberto N; Aureli M; Mauri L; Sonnino S
    Glycoconj J; 2021 Feb; 38(1):101-117. PubMed ID: 33620588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain Lipids and Lipid Droplet Dysregulation in Alzheimer's Disease and Neuropsychiatric Disorders.
    Zhao X; Zhang S; Sanders AR; Duan J
    Complex Psychiatry; 2023; 9(1-4):154-171. PubMed ID: 38058955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stereochemistry of Sphingolipids in Ganglioside GM3 Enhances Recovery of Nervous Functionality.
    Koolath S; Murai Y; Suzuki T; Swamy MMM; Usuki S; Monde K
    ACS Med Chem Lett; 2023 Sep; 14(9):1237-1241. PubMed ID: 37736188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Methods of Necroptosis Inhibition for Spinal Cord Injury Using Translational Research to Limit Secondary Injury and Enhance Endogenous Repair and Regeneration.
    Fiani B; Kondilis A; Soula M; Tao A; Alvi MA
    Neurospine; 2021 Jun; 18(2):261-270. PubMed ID: 33494555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.